title: Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen.
authors.affiliation: Department of Gastroenterology, Hospital Universitario 12 De Octubre , Madrid , Spain.
authors.forename: Nuria
authors.initials: N
authors.lastname: Dominguez
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Manzano
authors.forename: Raquel
authors.initials: R
authors.lastname: Muñoz
authors.forename: Ana
authors.initials: A
authors.lastname: Martin
authors.forename: Inmaculada
authors.initials: I
authors.lastname: Fernandez
authors.forename: Gregorio
authors.initials: G
authors.lastname: Castellano
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000821:virology*; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D000069283:Rituximab / Q000008:administration & dosage; D013997:Time Factors; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000069283:Rituximab; D014740:Vidarabine; C024352:fludarabine